Healthcare major Walgreens Boots Alliance (NASDAQ:WBA) is removing online-only purchase limits on over-the-counter (OTC) fever-reducing products for children.
While the company had put the measures in place to limit excess purchasing patterns, it has now removed them as in-stock conditions have improved and supply can meet demand across the country.
Shares of the company have dropped about 12% over the past month while short interest remains sizable at about 4.2% at present. At the same time, analysts remain cautiously optimistic about the stock with a Moderate Buy consensus rating and an average price target of $43.71.
This still points to an 18.84% potential upside in WBA stock.
Read full Disclosure